STOCK TITAN

Oscar Health insider Mario Schlosser sells 750K shares

Oscar Health, Inc. (OSCR) director Mario Schlosser reported an option exercise-and-sale sequence involving Class A and Class B common stock on August 27–28, 2026.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Oscar Health, Inc. (OSCR) director Mario Schlosser reported an option exercise-and-sale sequence involving Class A and Class B common stock on August 27–28, 2026. He exercised fully vested stock options with a $9.75 exercise price, covering in total 750,000 shares of Class B common stock, which were then converted into Class A common stock on a one-to-one basis.

Across the two days, Schlosser reported open-market sales of 750,000 shares of Class A common stock, including 600,000 shares at a weighted average price of $30.34 (range $29.98–$30.73) and 150,000 shares at a weighted average price of $30.79 (range $30.59–$30.89). The exercised stock options expire on December 16, 2029. Separate from these transactions, trusts associated with Schlosser hold Class B common stock convertible into an aggregate of 1,104,999 shares of Class A common stock, and he disclaims beneficial ownership of those trust-held shares except to the extent of any pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider Schlosser Mario
Role Director
Sold 750,000 shs ($22.82M)
Approx. gross sale proceeds $22.82M
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F5 150,000 $0.00 $0.00
Exercise Class B Common Stock F1 150,000 $9.75 $1.46M
Conversion Class B Common Stock F1 150,000 $0.00 $0.00
Conversion Class A Common Stock F1, F2 150,000 -- --
Sale Class A Common Stock F4, F2 150,000 $30.79 $4.62M
Exercise Stock Option (Right to Buy) F5 600,000 $0.00 $0.00
Exercise Class B Common Stock F1 600,000 $9.75 $5.85M
Conversion Class B Common Stock F1 600,000 $0.00 $0.00
Conversion Class A Common Stock F1, F2 600,000 -- --
Sale Class A Common Stock F3, F2 600,000 $30.34 $18.20M
holding Class B Common Stock F1, F6 -- -- --
holding Class B Common Stock F1, F6 -- -- --
holding Class B Common Stock F1, F6 -- -- --
Holdings After Transaction: Stock Option (Right to Buy) — 2,990,000 contracts (Direct); Class B Common Stock — 1,212,293 contracts (Direct); Class A Common Stock — 480,866 shares (Direct); Class B Common Stock — 283,333 contracts (Indirect, By Siena Pizzo-Schlosser Dynasty Trust); Class B Common Stock — 283,333 contracts (Indirect, By Noah Pizzo-Schlosser Dynasty Trust); Class B Common Stock — 538,333 contracts (Indirect, By Pizzo-Schlosser Family Dynasty Trust)
Footnotes (6)
  1. F1. The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.
  2. F2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.
  3. F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.98 to $30.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  4. F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.59 to $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  5. F5. The stock option is fully vested and exercisable, and expires on December 16, 2029.
  6. F6. Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any.
Shares sold August 27, 2026 600,000 shares of Class A Common Stock Reported sale at weighted average price with range $29.98–$30.73
Weighted average sale price August 27, 2026 $30.34 per share Class A Common Stock sold in multiple transactions
Shares sold August 28, 2026 150,000 shares of Class A Common Stock Reported sale at weighted average price with range $30.59–$30.89
Weighted average sale price August 28, 2026 $30.79 per share Class A Common Stock sold in multiple transactions
Stock option exercise price $9.75 per share Exercise price for fully vested stock options on Class B Common Stock
Options underlying shares exercised 750,000 shares of Class B Common Stock Total underlying shares for exercised stock options across August 27–28, 2026
Option expiration date December 16, 2029 Expiration date of the fully vested stock option described in the filing
Indirect convertible holdings via trusts 1,104,999 underlying shares of Class A Common Stock Class B Common Stock held by three dynasty trusts, convertible one-to-one into Class A
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
beneficial ownership financial
"Mr. Schlosser disclaims beneficial ownership over the shares held of record"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"except to the extent of his pecuniary interest therein, if any."
convertible financial
"The Class B common stock is convertible at any time at the option"
A convertible is a type of investment that starts as a loan or preferred stake (like a bond or preferred share) but can be exchanged for common shares of the company at a set price or under certain conditions. It matters to investors because it offers a mix of steady income and downside protection like a loan, plus the upside of stock ownership if the company does well—similar to holding a coupon that you can trade for a full ticket if the event becomes valuable.

FAQ

What did Mario Schlosser report in this Form 4 for OSCR?

Mario Schlosser reported exercising stock options for 750,000 shares of Class B common stock at a $9.75 exercise price, converting them into Class A shares, and selling 750,000 Class A shares in open-market or private transactions on August 27–28, 2026.

How many Oscar Health (OSCR) shares did Mario Schlosser sell and at what prices?

He reported selling 600,000 Class A shares on August 27, 2026 at a weighted average price of $30.34 (range $29.98–$30.73) and 150,000 Class A shares on August 28, 2026 at a weighted average price of $30.79 (range $30.59–$30.89).

What options did Mario Schlosser exercise in this OSCR filing?

He exercised fully vested stock options to acquire a total of 750,000 shares of Class B common stock at an exercise price of $9.75 per share. According to the filing, these options are fully vested and expire on December 16, 2029.

How are Oscar Health (OSCR) Class B shares treated in this Form 4?

The filing states that Class B common stock is convertible into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock after a specified time and events described in Oscar Health’s certificate of incorporation.

What indirect holdings in OSCR does Mario Schlosser report through trusts?

Trusts associated with Mario Schlosser hold Class B common stock convertible into 283,333, 283,333, and 538,333 Class A shares, respectively. Schlosser disclaims beneficial ownership of these trust-held shares except to the extent of any pecuniary interest.

Were the reported OSCR stock sales made under a Rule 10b5-1 trading plan?

The Form 4 does not indicate that the transactions were made pursuant to a Rule 10b5-1 trading plan. The document-level checkbox for Rule 10b5-1 is not marked as being used for these transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Schlosser Mario

(Last)(First)(Middle)
75 VARICK STREET, 5TH FLOOR

(Street)
NEW YORK NEW YORK 10013

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Oscar Health, Inc. [ OSCR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/27/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock08/27/2026C600,000A(1)1,080,866(2)D
Class A Common Stock08/27/2026S600,000D$30.34(3)480,866(2)D
Class A Common Stock08/28/2026C150,000A(1)630,866(2)D
Class A Common Stock08/28/2026S150,000D$30.79(4)480,866(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$9.7508/27/2026M600,000 (5)12/16/2029Class B Common Stock600,000$03,140,000D
Class B Common Stock(1)08/27/2026M600,000 (1) (1)Class A Common Stock600,000$9.751,812,293D
Class B Common Stock(1)08/27/2026C600,000 (1) (1)Class A Common Stock600,000$0(1)1,212,293D
Stock Option (Right to Buy)$9.7508/28/2026M150,000 (5)12/16/2029Class B Common Stock150,000$02,990,000D
Class B Common Stock(1)08/28/2026M150,000 (1) (1)Class A Common Stock150,000$9.751,362,293D
Class B Common Stock(1)08/28/2026C150,000 (1) (1)Class A Common Stock150,000$0(1)1,212,293D
Class B Common Stock(1) (1) (1)Class A Common Stock283,333283,333IBy Siena Pizzo-Schlosser Dynasty Trust(6)
Class B Common Stock(1) (1) (1)Class A Common Stock283,333283,333IBy Noah Pizzo-Schlosser Dynasty Trust(6)
Class B Common Stock(1) (1) (1)Class A Common Stock538,333538,333IBy Pizzo-Schlosser Family Dynasty Trust(6)
Explanation of Responses:
1. The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.
2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.98 to $30.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.59 to $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
5. The stock option is fully vested and exercisable, and expires on December 16, 2029.
6. Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any.
Remarks:
/s/Melissa Curtin, Attorney-in-Fact08/31/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)